Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has... 12 KB (997 words) - 22:21, 31 December 2023 |
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical... 18 KB (1,318 words) - 13:22, 28 March 2024 |
against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute... 7 KB (436 words) - 17:19, 13 March 2024 |
"Covid-19: UK orders extra 40m doses of Valneva vaccine". BBC News. 1 February 2021. Archived from the original on 3 February 2021. Retrieved 1 February... 347 KB (33,588 words) - 08:02, 5 April 2024 |
based rabies vaccine approved by the World Health Organization. Ixiaro by Valneva SE for Japanese encephalitis. Audsley JM, Tannock GA (1 August 2008). "Cell-based... 16 KB (1,533 words) - 02:48, 30 January 2023 |
Kingdom United States VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies. Full (1) United Kingdom Emergency (32) Bahrain... 318 KB (19,351 words) - 20:33, 14 March 2024 |
Union Technologies Informatique Group Valneva SE Verimatrix Vilmorin & Cie Voluntis Wavestone X-FAB Silicon Foundries SE Xilam Animation Ymagis CAC 40 CAC... 5 KB (481 words) - 13:31, 27 December 2023 |
BioNTech (redirect from BioNTech SE) possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva". Reuters. London. Retrieved 2 August 2020. SE, BioNTech (5 August 2020). "Pfizer and BioNTech... 40 KB (3,633 words) - 02:16, 24 March 2024 |